Glomerular filtration rate in patients with psoriasis treated with etanercept

Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest

(2015) K. Reich et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study

(2015) H.-Y. Chiu et al.   BRITISH JOURNAL OF DERMATOLOGY

Estimating glomerular filtration rate

(2013) Daniel P. Murphy et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study

(2013) J. Wan et al.   BMJ-British Medical Journal

Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry

(2012) P. Gisondi et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Notice

(2012)   Kidney International Supplements

Medical comorbidity associated with psoriasis in adults: a population-based study

(2011) Y-W. Yang et al.   BRITISH JOURNAL OF DERMATOLOGY

Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A?systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis

(2011) Amanda Robinson et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.

(2010) K Abuabara et al.   BRITISH JOURNAL OF DERMATOLOGY